[NP_P11] Poster Session 11

[NP-P11-6] Continuation of new antidepressant drugs in the second-line treatment of major depression:A multisite collaborative randomized flexible-dose open-label clinical trial

^○Yuma Yokoi¹, Naoki Yoshimura¹, Kenji Hatano¹, Takayuki Abe², Atsuo Nakagawa², Ken Inada³, Tomiki Sumiyoshi¹, Koichiro Watanabe⁴, Takashi Tsuboi⁴, Yumiyo Morokawa⁵, Akira Iwanami⁶, Masaru Mimura⁷, Toshiaki Furukawa⁸, Gentaro Nishioka⁹, Hideki Oi¹, Kazuyuki Nakagome¹ (1. National Center of Neurology and Psychiatry, 2. Keio University Hospital Clinical and Translational Research Center, 3. Department of Psychiatry, Tokyo Women’s Medical University, 4. Department of Neuropsychiatry, Kyorin University School of Medicine, 5. Seimou Hospital Clinical Medicine Research Center, 6. Department of Psychiatry, Showa Karasuyama Hospital, 7. Department of Neuropsychiatry, Keio University School of Medicine, 8. Departments of Health Promotion and Human Behavior and of Clinical Epidemiology Kyoto University Graduate School of Medicine, 9. Kawaguchi Clinic)